Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can ...

However, there is a new opportunity for lung cancer patients. It is called adjuvant therapy. It is designed to prevent the ...

According to Henry Ford Health, lung cancer often doesn’t show symptoms until it’s in a more advanced stage. Early detection ...

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid ...

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...

Panelists discuss how HER2-directed therapies in non–small cell lung cancer (NSCLC) are evolving, with experts examining the distinction between HER2 mutation and expression, evaluating the efficacy ...

Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell ...

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds.

Dr. Leal discusses how the primary goals of therapy for patients with extensive stage small cell lung cancer (ES-SCLC) include balancing the potential survival benefits of subsequent treatment lines ...

People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both ...

Survival in NSCLC improved with guideline-concordant care in lung cancer, and several factors can be addressed to reach more ...

USA Today reports on how the former president benefitted after a diagnosis that just years prior would have been terminal. Cancer therapies have enabled him to celebrate his 100th birthday this week.